Prostaglandin-synthetase inhibition with diclofenac sodium in treatment of renal colic: comparison with use of a narcotic analgesic.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000701:Analgesics, Opioid / Q000009:adverse effects / Q000627:therapeutic use*; D003061:Codeine / Q000009:adverse effects / Q000627:therapeutic use*; D003085:Colic / Q000188:drug therapy*; D016861:Cyclooxygenase Inhibitors; D004008:Diclofenac / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004311:Double-Blind Method; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007674:Kidney Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000009:adverse effects / Q000627:therapeutic use*; D009665:Noscapine / Q000009:adverse effects / Q000627:therapeutic use*; D010208:Papaverine / Q000009:adverse effects / Q000627:therapeutic use*; D010648:Phenylacetates / Q000627:therapeutic use*; D011897:Random Allocation; D012602:Scopolamine Derivatives / Q000009:adverse effects / Q000627:therapeutic use*
D000701:Analgesics, Opioid; D016861:Cyclooxygenase Inhibitors; D004338:Drug Combinations; D010648:Phenylacetates; D012602:Scopolamine Derivatives; D004008:Diclofenac; D009020:Morphine; C034701:spasmofen; D009665:Noscapine; D010208:Papaverine; D003061:Codeine